Clinical Trials

Provision Clinical Trials serves as an independent research site, consistently delivering excellence in patient care and study performance that meets research requirements and builds strong relationships with physician and sponsor partners.

Listed below are Active and Upcoming Clinical Trials. “Active” status means that Provision Center for Biomedical Research is actively involved in the trial, which may or may not be accepting new patients. Active status has two types: “Active: Open to Patient Enrollment” status is in the patient recruitment phase, where patients are welcome to enroll, provided they meet the study criteria; or “Active: Closed to Patient Enrollment”, where the study is still active in collecting data, but is closed to enrolling new patients. Should patients be interested in a trial that is closed to enrollment, they may inquire about other studies where they might qualify to participate.

If you would like more information on our clinical trials or want to learn more about enrollment, please CONTACT US

Active and Upcoming Clinical Trials

Listing Title
Listing Category
Description


A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

Study Status
Upcoming Trial
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Title
Listing Category
Description


A single-arm, open-label, Phase 2 study evaluating A single-arm, open-label, Phase 2 study evaluating by an On Body Delivery System, in combination with weekly carfilzomib and dexamethasone in adult participants with relapsed and/or refractory multiple myeloma (RRMM)

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Saji Eapen, Tennessee Cancer Specialists
Listing Category
Study Status
Upcoming Trial
Principal Investigator
Dr. John Swisher, StatCare Medical Group
Listing Title
Listing Category
Description


A randomized, double-blinded, placebo-controlled, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with idiopathic pulmonary fibrosis

Study Status
Active: Closed to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Category
Description


An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Category
Description


A randomized, double-blinded, placebo-controlled, multinational, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with progressive pulmonary fibrosis

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Study Status
Upcoming Trial
Principal Investigator
Dr. Monica Crane, Tennessee Memory Disorder Foundation
Listing Category
Description


MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.

Study Status
Upcoming Trial
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Title
Listing Category
Description


The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) as measured by the change in 6-Minute Walk Distance. Participants will be eligible for an open label extension (OLE) of 52 weeks.

Study Status
Upcoming Trial
Trial Documentation:
Principal Investigator
Dr. John Swisher, StatCare Medical Group
Listing Category
Description


A Study of Remternetug Versus Placebo in Early Alzheimer’s Disease Participants at Risk for Cognitive and Functional Decline

Study Status
Active: Closed to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Monica Crane, Tennessee Memory Disorder Foundation
Scroll to Top